Approval · Notice of Compliance 3050 · 1998
SINGULAIR: Notice of Compliance 3050
Issued June 17, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3050
- Date
- June 17, 1998
- Company
- Merck Sharp & Dohme Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Leukotriene receptor antagonist
Products in this notice
Medicinal ingredients
- MONTELUKAST SODIUM 5 MG per TAB
- MONTELUKAST SODIUM 10 MG per TAB